{"id":994274,"date":"2026-08-12T11:48:54","date_gmt":"2026-08-12T15:48:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/"},"modified":"2026-08-12T11:48:54","modified_gmt":"2026-08-12T15:48:54","slug":"lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/","title":{"rendered":"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ATLANTA, Aug.  12, 2026  (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits:<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>ARS Pharmaceuticals, Inc. (SPRY)<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The shareholder class action lawsuit filed against ARS Pharmaceuticals, Inc. (\u201cARS\u201d) (NASDAQ: SPRY) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts between March 9, 2026 and June 24, 2026 regarding ARS\u2019s expected timeline for expanded insurance coverage for its epinephrine nasal spray, neffy, with CVS Caremark. If you purchased ARS shares during this time period and suffered a loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vtmJjKfqvIiMiXCXpUV4o9TJek9m0W-5uzJCS0LKEe_ohsFBZ5xVqaOTFuZbqROm3_avfiQTKAOeguExQJAV_00bHkf06O00JZnmAeFnwKM=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Hf08ytT8uCOeG4Mp9crqCYPeRxjFENOqFjjlwl7pEy8EXbGP-lbOYlDIcJQBxwXEJowng2Che98LrM3si8cMqh9yPL6xJqj1gB0K-TGZ2JGBAeXWIDjJkmx6_3se1oKI5USsMjytU9ATouve4AvfLopQXPl2ZmpPTGEZZg9nOmk=\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/ars-pharmaceuticals\/ <\/a>to learn more. \u00a0\u00a0\u00a0<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is October 5, 2026.\u00a0<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Alarum Technologies Ltd. (ALAR)<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The shareholder class action lawsuit filed against Alarum Technologies Ltd. (\u201cAlarum\u201d) (NASDAQ: ALAR) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts between March 20, 2025 and July 2, 2026 regarding the impact of Alarum\u2019s subsidiary, NetNut, on its legal exposure and business prospects. If you purchased Alarum shares during this time period and suffered a loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vtmJjKfqvIiMiXCXpUV4o9TJek9m0W-5uzJCS0LKEe8DtCvVPTHRUcmkKEi8SNh4sms7csDXTQiJWGITuJ4_rWvbIttkd85P-1ylVQL3b4E=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Hf08ytT8uCOeG4Mp9crqCYPeRxjFENOqFjjlwl7pEy-UlqL8gtE3AGLaqxbOJj6ZFbXKaCNHU4Dm43Px9XzxagElCwioIpo1qDLatJb08jLJMOzLjJVVbpFLN4-c_zSEqbiqqUneVK5azK2t-jhjObnbMvEod653sKUuoweY80M=\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/alarum-technologies\/<\/a> to learn more.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is October 5, 2026.\u00a0<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Blaize Holdings, Inc. (BZAI)<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The shareholder class action lawsuit filed against Blaize Holdings, Inc. (\u201cBlaize\u201d) (NASDAQ: BZAI) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts between July 18, 2025 and April 28, 2026 regarding Blaize\u2019s alleged improperly recognized revenue. If you purchased Blaize shares during this time period and suffered a loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vtmJjKfqvIiMiXCXpUV4o9TJek9m0W-5uzJCS0LKEe8QTFKsEFu0pF7VJorOJLaGGk_7h19MPhiilVD1nB35FSGwaUlxQ8vB2dPMzedJK6I=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Hf08ytT8uCOeG4Mp9crqCYPeRxjFENOqFjjlwl7pEy9a6v9XlWJ8r1NPOyrFY-pSKmrhcL10A4jO_a64oa39YEo2qrYu2UiOIPvPqf87wEogVYHiDCpeLo7pc18t2oUKXfy_anZfUp12t20Sx2g5pw==\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/blaize-holdings\/<\/a> to learn more.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is October 5, 2026.\u00a0<\/strong>\n      <\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=B-Ek4Lom5Np0bmDD94YBa5aFvhjf1FzE3p1RsgHrtL-ewwOKkZdvU8JTkciB2N8fqtr9RHZV72S-OKP8Ou-58SKYyu6HvxMiOdcQ0bKzL3k=\" rel=\"nofollow\" target=\"_blank\">https:\/\/holzerlaw.com\/<\/a>,\u202fand upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.\u202f\u00a0<\/p>\n<p align=\"justify\">CONTACT:<br \/>Corey Holzer, Esq.<br \/>(888) 508-6832 (toll-free) <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vtmJjKfqvIiMiXCXpUV4o9TJek9m0W-5uzJCS0LKEe8lwokfcGA4mWHgMGADMHlTA6ttLDiq2Bj24clO2TLCTqGs4bP6l_g_KI6-63rgd9o=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwODc3NSM3NzczMDQxIzIxODA3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NmIzZjhmNTYtOTQzNy00ZmMyLWJhNGEtOWY3NzQ2ODMyYTE0LTExOTIzMzYtMjAyNi0wOC0xMi1lbg==\/tiny\/Holzer-Holzer.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, Aug. 12, 2026 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: ARS Pharmaceuticals, Inc. (SPRY) The shareholder class action lawsuit filed against ARS Pharmaceuticals, Inc. (\u201cARS\u201d) (NASDAQ: SPRY) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts between March 9, 2026 and June 24, 2026 regarding ARS\u2019s expected timeline for expanded insurance coverage for its epinephrine nasal spray, neffy, with CVS Caremark. If you purchased ARS shares during this time period and suffered a loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-994274","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, Aug. 12, 2026 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: ARS Pharmaceuticals, Inc. (SPRY) The shareholder class action lawsuit filed against ARS Pharmaceuticals, Inc. (\u201cARS\u201d) (NASDAQ: SPRY) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts between March 9, 2026 and June 24, 2026 regarding ARS\u2019s expected timeline for expanded insurance coverage for its epinephrine nasal spray, neffy, with CVS Caremark. If you purchased ARS shares during this time period and suffered a loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free &hellip; Continue reading &quot;Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-12T15:48:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwODc3NSM3NzczMDQxIzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC\",\"datePublished\":\"2026-08-12T15:48:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\\\/\"},\"wordCount\":538,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwODc3NSM3NzczMDQxIzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\\\/\",\"name\":\"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwODc3NSM3NzczMDQxIzIxODA3Njc=\",\"datePublished\":\"2026-08-12T15:48:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwODc3NSM3NzczMDQxIzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwODc3NSM3NzczMDQxIzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/","og_locale":"en_US","og_type":"article","og_title":"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk","og_description":"ATLANTA, Aug. 12, 2026 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: ARS Pharmaceuticals, Inc. (SPRY) The shareholder class action lawsuit filed against ARS Pharmaceuticals, Inc. (\u201cARS\u201d) (NASDAQ: SPRY) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts between March 9, 2026 and June 24, 2026 regarding ARS\u2019s expected timeline for expanded insurance coverage for its epinephrine nasal spray, neffy, with CVS Caremark. If you purchased ARS shares during this time period and suffered a loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free &hellip; Continue reading \"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-12T15:48:54+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwODc3NSM3NzczMDQxIzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC","datePublished":"2026-08-12T15:48:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/"},"wordCount":538,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwODc3NSM3NzczMDQxIzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/","name":"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwODc3NSM3NzczMDQxIzIxODA3Njc=","datePublished":"2026-08-12T15:48:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwODc3NSM3NzczMDQxIzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwODc3NSM3NzczMDQxIzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-ars-pharmaceuticals-inc-spry-alarum-technologies-ltd-alar-and-blaize-holdings-inc-bzai-announced-by-holzer-holz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer &amp; Holzer, LLC"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/994274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=994274"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/994274\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=994274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=994274"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=994274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}